Val-Ala-PABC-N (Mesylpropane) -Exatecan

Val-Ala-PABC-N (Mesylpropane) -Exatecan is an agent-linker conjugate for ADC. Val-Ala-PABC-N (Mesylpropane) -Exatecan is a Exatecan (a DNA topoisomerase I inhibitor) d with cleavable Val-Ala-PABC-N (Mesylpropane) linker[1].

Product Specifications

CAS Number

[2842021-73-0]

UNSPSC

12352203

Target

Drug-Linker Conjugates for ADC

Type

Reference compound

Related Pathways

Antibody-drug Conjugate/ADC Related

Applications

Cancer-programmed cell death

Field of Research

Cancer

Assay Protocol

https://www.medchemexpress.com/val-ala-pabc-n-mesylpropane-exatecan.html

Smiles

CC(C)[C@H](N)C(N[C@@H](C)C(NC(C=C1)=CC=C1COC(N(CCS(C)(=O)=O)COCC(N[C@@H]2C3=C4C(C(N5C4)=CC([C@](O)(C(OC6)=O)CC)=C6C5=O)=NC7=CC(F)=C(C)C(CC2)=C73)=O)=O)=O)=O

Molecular Formula

C46H54FN7O12S

Molecular Weight

948.02

References & Citations

[1]Cheng X, et al. MORAb-202, an Antibody-Drug Conjugate Utilizing Humanized Anti-human FRα Farletuzumab and the Microtubule-targeting Agent Eribulin, has Potent Antitumor Activity. Mol Cancer Ther. 2018 Dec;17 (12) :2665-2675.